Additionally, analysis of a cohort of more than 160 AML patients treated by induction chemotherapy in The Cancer Genome Atlas (TCGA) showed that low MTF2 transcript levels in bulk BM RNA correlated with lower survival [13]. Here, MTF2 is linked to acute myeloid leukemia.